Featured Expertise
We understand the nuances of your category from day one.
Can’t see your therapeutic area?
VIEW ALL EXPERTISE3D MOA ANIMATION
This 3D medical animation details the MOA of Aflibercept, a pioneering bispecific fusion protein for retinal diseases like neovascular AMD. We visualize the pathophysiology involving VEGFR-1 and VEGFR-2. The animation demonstrates Aflibercept's superior multi-targeted blockade: it traps all ligands of VEGFR-1 and key ligands of VEGFR-2, providing comprehensive inhibition of vascular leakage and neovascularization. This showcases our expertise in Ophthalmology and Anti-VEGF pharmacology.
3D MOA ANIMATION
This 3D medical animation details the MOA of Aflibercept, a pioneering bispecific fusion protein for retinal diseases like neovascular AMD. We visualize the pathophysiology involving VEGFR-1 and VEGFR-2. The animation demonstrates Aflibercept's superior multi-targeted blockade: it traps all ligands of VEGFR-1 and key ligands of VEGFR-2, providing comprehensive inhibition of vascular leakage and neovascularization. This showcases our expertise in Ophthalmology and Anti-VEGF pharmacology.
.svg)